Shewanella putrefaciens is a gram-negative bacillus belonging to the family Vibrionaceae (7). It is widely distributed in nature; its natural habitats are water and soil (11). This organism has rarely been isolated from clinical material. We report here a case of bacteremia with S. putrefaciens in a rheumatic heart disease patient with infective endocarditis in which an etiological association was made due to the organism’s isolation twice from blood and echocardiographic evidence of a vegetation on the anterior mitral leaflet.
An immunocompetent 24-year-old female with rheumatic heart disease and mitral and aortic valve insufficiency presented with high-grade fever of 15 days’ duration. On examination of the patient, no evidence of congestive heart failure was found.
Two complete sets (one aerobic and one anaerobic culture bottle each) of blood for cultures were collected at an interval of 30 min for aerobic and anaerobic bacterial isolation. S. putrefaciens and Streptococcus viridans were isolated from both sets of blood culture bottles after 24 h of aerobic incubation. No anaerobic organisms were isolated.
S. putrefaciens was identified by its biochemical reactions at 24 h (5). This organism produced nonhemolytic tan colonies on 5% sheep blood agar. Salmon pink colonies were seen on MacConkey agar. The organism was motile and produced hydrogen sulfide on triple sugar iron agar. It was positive for ornithine decarboxylase, gelatin, oxidase, and citrate. It failed to ferment sugars and was negative for O-nitrophenyl-β-galactase, arginine decarboxylase, lysine decarboxylase, tryptophan deaminase, and indole and in the Voges-Proskauer test. Identification of the isolate as S. putrefaciens was confirmed by the API 20E system (bioMerieux Vitek, Inc., Hazelwood, Mo.). In a standard Kirby-Bauer sensitivity test (8), the organism was sensitive to amikacin, gentamicin, cefotaxime, and piperacillin.
Echocardiography revealed the presence of a vegetation on the anterior mitral leaflet, thus confirming the diagnosis of infective endocarditis. Treatment with parenteral gentamicin and penicillin was begun and continued for 3 weeks. The patient improved once the treatment was started and was discharged at the end of the treatment period.
Viridans streptococci are the most common infectious agents in subacute bacterial endocarditis and may occasionally be accompanied by other bacteria (2), as was seen in this case. Infections due to S. putrefaciens include chronic leg ulcers (1), infections of the ear (10), abscesses (12), and septicemia (4, 6, 9).
The possible risk factors for bloodstream infection by S. putrefaciens are (i) prematurity and congenital pneumonia, (ii) ulceration of the lower extremities, and (iii) an underlying debility (3). In our patient, the source of infection could not be documented.
A high incidence of polymicrobial bacteremia with S. putrefaciens has been reported (3, 4, 6), as was observed in our case. The association of S. putrefaciens with subacute bacterial endocarditis in an immunocompetent patient further extends the clinical spectrum of this opportunistic pathogen.
REFERENCES
- 1.Appelbaum P C, Bowen A J. Opportunistic infection of chronic skin ulcers with Pseudomonas putrefaciens. Br J Dermatol. 1978;98:229–231. doi: 10.1111/j.1365-2133.1978.tb01628.x. [DOI] [PubMed] [Google Scholar]
- 2.Baddour L M, Meyer J, Henry B. Polymicrobial infective endocarditis in the 1980’s. Rev Infect Dis. 1991;13:963–970. doi: 10.1093/clinids/13.5.963. [DOI] [PubMed] [Google Scholar]
- 3.Brink A J, Straten A, Rensburg A J. Shewanella (Pseudomonas) putrefaciens bacteremia. Clin Infect Dis. 1995;20:1327–1332. doi: 10.1093/clinids/20.5.1327. [DOI] [PubMed] [Google Scholar]
- 4.Eschete M L, Williams F, West B C. Pseudomonas putrefaciens and group A beta-hemolytic streptococcus septicemia. Arch Intern Med. 1980;140:1533–1534. [PubMed] [Google Scholar]
- 5.Gilardi G L. Pseudomonas. In: Lennette E H, Balows A, Hausler W J, Shadomy H J, editors. Manual of clinical microbiology. 4th ed. Washington, D.C: American Society for Microbiology; 1985. pp. 350–372. [Google Scholar]
- 6.Kim J H, Cooper R A, Welty-Wolf K E, Harrell L J, Zwadyk P, Klotman M E. Pseudomonas putrefaciens bacteremia. Rev Infect Dis. 1989;11:97–104. [PubMed] [Google Scholar]
- 7.MacDonell M T, Colwell R R. Phylogeny of the Vibrionaceae and recommendation for 2 new genera, Listonella and Shewanella. Syst Appl Microbiol. 1985;6:171–182. [Google Scholar]
- 8.National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility testing of aerobic bacteria: approved standard. 4th ed. NCCLS document M2-A4. Villanova, Pa: National Committee for Clinical Laboratory Standards; 1992. [Google Scholar]
- 9.Schmidt U, Kapila R, Kaminski Z, Louria D. Pseudomonas putrefaciens as a cause of septicemia in humans. J Clin Microbiol. 1979;10:385–387. doi: 10.1128/jcm.10.3.385-387.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Von Graevenitz A. Clinical microbiology of unusual Pseudomonas species. Prog Clin Pathol. 1973;5:185–218. [PubMed] [Google Scholar]
- 11.Von Graevenitz A. Ecology, clinical significance and antimicrobial susceptibility of infrequently encountered glucose-nonfermenting gram-negative rods. In: Gilardi G L, editor. Nonfermentative gram-negative rods: laboratory identification and clinical aspects. New York, N.Y: Marcel Dekker; 1985. p. 199. [Google Scholar]
- 12.Yohe S, Fishbain J T, Andrews M. Shewanella putrefaciens abscess of the lower extremity. J Clin Microbiol. 1997;35:3363. doi: 10.1128/jcm.35.12.3363-3363.1997. . (Letter.) [DOI] [PMC free article] [PubMed] [Google Scholar]